T-cell response to phytohemagglutinin in the interferon-γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non-small cell lung cancer.
Chisato KamimakiNobuaki KobayashMomo HirataKohei SomekawaNobuhiko FukudaSousuke KuboSeigo KatakuraShuhei TeranishiKeisuke WatanabeNobuyuki HoritaYu HaraMasaki YamamotoMakoto KudoHongmei PiaoTakeshi KanekoPublished in: Thoracic cancer (2021)
The T-SPOT.TB assay can be used to quantify the number of immunospots in response to antigen stimulation, which may predict the response to immune checkpoint inhibitors in patients with non-small cell lung cancer.